Unternehmen Easton Pharmaceuticals Inc. Other OTC
Aktien
A1CUUH
US2777741057
EAPH
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30.06.15 |
Vince Demasi
COO | Chief Operating Officer | - | 20.06.18 |
Chief Tech/Sci/R&D Officer | - | 01.01.15 | |
John Guerra
SEC | Corporate Secretary | - | 31.12.13 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30.06.15 |
John Guerra
SEC | Corporate Secretary | - | 31.12.13 |
Vince Demasi
COO | Chief Operating Officer | - | 20.06.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 1 309 122 163 | 1 309 122 163 ( 100,00 %) | 0 | 100,00 % |
Unternehmenskontakt
![Straße Easton Pharmaceuticals Inc.(EAPH)](https://cdn.zonebourse.com/static/address/6058586.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+16.21% | 122 Mrd. | |
+19.54% | 113 Mrd. | |
+3.17% | 22.66 Mrd. | |
-17.10% | 21.34 Mrd. | |
-39.57% | 16.92 Mrd. | |
-14.19% | 16.68 Mrd. | |
-16.22% | 16.61 Mrd. | |
+3.09% | 13.62 Mrd. | |
+21.34% | 11.04 Mrd. |